Literature DB >> 7526886

Tumour angiogenesis in latent prostatic carcinoma.

M Furusato1, S Wakui, H Sasaki, K Ito, S Ushigome.   

Abstract

Unrestrained growth of various malignant tumours has been shown to depend upon a critical number of tumour cells which have switched to the angiogenic phenotype. Angiogenic phenotypes were noted in the early stage of prostatic carcinoma (PCa). We investigated 65 cases of latent PCa to define the correlation between tumour angiogenesis and tumour volume. Tumour angiogenesis was determined by the blood capillary density ratio (BCDR) evaluated by a colour image analysis system. Using experimental regression analysis, the correlation between the BCDR and PCa volume was divisible into two distinct stages. When the PCa showed a volume of more than 83 mm3, there was a significant positive correlation between the BCDR and PCa volume (rS-test P < 0.001). However, when the PCa showed a volume of less than 83 mm3, the BCDR remained at a low level which did not change until larger volumes were present (rS-test, NS; ANOVA, NS). The present study suggested that latent PCa showing a volume of less than 83 mm3 would be 'early' indolent carcinoma which, on undergoing additional events concerning tumour angiogenesis, would assume more aggressive growth.

Entities:  

Mesh:

Year:  1994        PMID: 7526886      PMCID: PMC2033660          DOI: 10.1038/bjc.1994.480

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy.

Authors:  L Révész; E Siracka; J Siracky; G Delides; K Pavlaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-05       Impact factor: 7.038

2.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate.

Authors:  J E McNeal; A A Villers; E A Redwine; F S Freiha; T A Stamey
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

Review 3.  Early detection of prostate cancer.

Authors:  P T Scardino
Journal:  Urol Clin North Am       Date:  1989-11       Impact factor: 2.241

4.  Monoclonal antibodies specific for vimentin.

Authors:  M Osborn; E Debus; K Weber
Journal:  Eur J Cell Biol       Date:  1984-05       Impact factor: 4.492

5.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.

Authors:  R L Barnhill; K Fandrey; M A Levy; M C Mihm; B Hyman
Journal:  Lab Invest       Date:  1992-09       Impact factor: 5.662

6.  Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study.

Authors:  S Wakui; M Furusato; T Itoh; H Sasaki; A Akiyama; I Kinoshita; K Asano; T Tokuda; S Aizawa; S Ushigome
Journal:  J Pathol       Date:  1992-11       Impact factor: 7.996

7.  Comparison of microscopic vascularity in benign and malignant prostate tissue.

Authors:  S A Bigler; R E Deering; M K Brawer
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

Review 8.  The role of angiogenesis in tumor growth.

Authors:  J Folkman
Journal:  Semin Cancer Biol       Date:  1992-04       Impact factor: 15.707

9.  Microvessel quantitation and prognosis in invasive breast carcinoma.

Authors:  S Bosari; A K Lee; R A DeLellis; B D Wiley; G J Heatley; M L Silverman
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

10.  Quantitative morphometric analysis of the microcirculation in prostate carcinoma.

Authors:  M K Brawer; S A Bigler; R E Deering
Journal:  J Cell Biochem Suppl       Date:  1992
View more
  6 in total

1.  Incidental prostatic carcinoma. A predictive role of neoangiogenesis and comparison with other prognostic factors.

Authors:  M Volavsek; A Masera; Z Ovcak
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 2.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 4.  Tumor angiogenesis: the pivotal role of vascular endothelial growth factor.

Authors:  D Marmé
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study.

Authors:  Florian Michallek; Henkjan Huisman; Bernd Hamm; Sefer Elezkurtaj; Andreas Maxeiner; Marc Dewey
Journal:  Eur Radiol       Date:  2021-12-16       Impact factor: 7.034

6.  Mechanism underlying the negative effect of prostate volume on the outcome of extensive transperineal ultrasound-guided template prostate biopsy.

Authors:  Takayoshi Demura; Takenori Takada; Naohiko Shimoda; Takaya Hioka; Yoshihumi Iwaguchi; Shin Ichihara; Hiroko Gotoda
Journal:  Cancer Med       Date:  2018-01-17       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.